Dear Reader,
In Dylan’s interview with Laycee from Marketbeat, he discussed the weight-loss drug craze, the “smart chemo” revolution and his system for picking biotech stocks in any market.
Dylan says…
My younger friends often tease me about my focus on the biotech sector. They say I should drop that and focus on “cool” things like crypto.
I smile and remind them that crypto may indeed be cool. But Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in January. Or to $200,000 to match the 300% gains on Viking Therapeutics in March.
I’m old school. Ain’t nothing cool about me, except money.
Here’s a link to the interview.
